GR1003868B - Evaluation of the wound healing, antioxidant and cytostatic properties of mastic and its element and relative applications - Google Patents

Evaluation of the wound healing, antioxidant and cytostatic properties of mastic and its element and relative applications

Info

Publication number
GR1003868B
GR1003868B GR20010100053A GR2001100053A GR1003868B GR 1003868 B GR1003868 B GR 1003868B GR 20010100053 A GR20010100053 A GR 20010100053A GR 2001100053 A GR2001100053 A GR 2001100053A GR 1003868 B GR1003868 B GR 1003868B
Authority
GR
Greece
Prior art keywords
antioxidant
wound healing
mastic
evaluation
pharmaceutical
Prior art date
Application number
GR20010100053A
Other languages
Greek (el)
Inventor
Προκοπιος Μαγιατης
Σοφια Μητακου
Αλεξιος-Λεανδρος Σκαλτσουνης
Σπυριδων Φωτεινος
Original Assignee
Lavipharm S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lavipharm S.A. filed Critical Lavipharm S.A.
Priority to GR20010100053A priority Critical patent/GR1003868B/en
Publication of GR1003868B publication Critical patent/GR1003868B/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

he present invention refers to the use of a product deriving from the plant Pistacia lentiscus var. chia of the Anacardiaceae family as an antioxidant, as wound healing inductor and as cytostatic. The invention also refers to the utilisation of theproduct in the preparation of pharmaceutical concoctions. The pharmaceutical concoction dosage form may be selected from a group which includes, among others, tablets, cremes, ointments, solutions, suspensions, gels (aqueous gels), shampoos, epidermal and transdermal patches, as well as systems for its administration through the mucus membranes and systems for its administrations through the mucosa of the oral cavity.
GR20010100053A 2001-02-06 2001-02-06 Evaluation of the wound healing, antioxidant and cytostatic properties of mastic and its element and relative applications GR1003868B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20010100053A GR1003868B (en) 2001-02-06 2001-02-06 Evaluation of the wound healing, antioxidant and cytostatic properties of mastic and its element and relative applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20010100053A GR1003868B (en) 2001-02-06 2001-02-06 Evaluation of the wound healing, antioxidant and cytostatic properties of mastic and its element and relative applications

Publications (1)

Publication Number Publication Date
GR1003868B true GR1003868B (en) 2002-04-19

Family

ID=10944633

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010100053A GR1003868B (en) 2001-02-06 2001-02-06 Evaluation of the wound healing, antioxidant and cytostatic properties of mastic and its element and relative applications

Country Status (1)

Country Link
GR (1) GR1003868B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003092712A1 (en) * 2002-05-01 2003-11-13 Lavipharm S.A. Use of mastic and its components for the control of microbial infections
EP1520585A1 (en) * 2003-10-02 2005-04-06 Data Medica Padova S.p.A. Cancer treatment using natural plant products or essential oils or components from some pistacia species
WO2010100650A2 (en) 2009-03-04 2010-09-10 Regenera Pharma Ltd. Therapeutic uses of mastic gum fractions
WO2012032523A2 (en) 2010-09-07 2012-03-15 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
US8722105B2 (en) 2009-03-04 2014-05-13 Zadik Hazan Compositions of polymeric myrcene
EP3363448A1 (en) 2017-02-15 2018-08-22 Phytoitalia SRL Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them
WO2019170239A1 (en) 2018-03-08 2019-09-12 Phytoitalia Srl Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563109A1 (en) * 1984-04-18 1985-10-25 Truc Daniel Phytotherapeutic composition composed of plants containing oils, plants containing mineral salts, plants containing waxes, oxidases and mineral salts, which treats diseases of the airways, and process for preparing it
CN1154852A (en) * 1996-05-05 1997-07-23 于庆林 Multi-purpose ointment for injury or wound
US5725859A (en) * 1994-05-03 1998-03-10 Omer; Osama L.M. Plant-based therapeutic agent with virustatic and antiviral effect
WO2001021212A1 (en) * 1999-09-22 2001-03-29 Vassilios Papageorgiou A stable product of isohexylnaphthazarins with penta- and tetra-cyclic triterpenes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563109A1 (en) * 1984-04-18 1985-10-25 Truc Daniel Phytotherapeutic composition composed of plants containing oils, plants containing mineral salts, plants containing waxes, oxidases and mineral salts, which treats diseases of the airways, and process for preparing it
US5725859A (en) * 1994-05-03 1998-03-10 Omer; Osama L.M. Plant-based therapeutic agent with virustatic and antiviral effect
CN1154852A (en) * 1996-05-05 1997-07-23 于庆林 Multi-purpose ointment for injury or wound
WO2001021212A1 (en) * 1999-09-22 2001-03-29 Vassilios Papageorgiou A stable product of isohexylnaphthazarins with penta- and tetra-cyclic triterpenes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A.-H. Y. ABDEL-RAHMAN ET AL.: "MASTICH AS AN ANTIOXIDANT", JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY., vol. 52, no. 10, 1975, AMERICAN OIL CHEMISTS' SOCIETY. CHAMPAIGN., US, pages 423, XP001024781, ISSN: 0003-021X *
C.B. LESESNE: "THE POSTOPERATIVE USE OF WOUND ADHESIVES", JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, vol. 18, no. 11, November 1992 (1992-11-01), pages 990, XP001030919 *

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003092712A1 (en) * 2002-05-01 2003-11-13 Lavipharm S.A. Use of mastic and its components for the control of microbial infections
EP1520585A1 (en) * 2003-10-02 2005-04-06 Data Medica Padova S.p.A. Cancer treatment using natural plant products or essential oils or components from some pistacia species
US9655938B2 (en) 2009-03-04 2017-05-23 Regenera Pharma Ltd. Compositions of polymeric myrcene
CN106619700A (en) * 2009-03-04 2017-05-10 瑞吉纳拉制药公司 Therapeutic uses of mastic gum fractions
US8722105B2 (en) 2009-03-04 2014-05-13 Zadik Hazan Compositions of polymeric myrcene
AU2010220057B2 (en) * 2009-03-04 2015-04-02 Regenera Pharma Ltd. Compositions of polymeric myrcene
AU2010220057C1 (en) * 2009-03-04 2015-10-29 Regenera Pharma Ltd. Compositions of polymeric myrcene
EP3578191A1 (en) 2009-03-04 2019-12-11 Regenera Pharma Ltd. Compositions of polymeric myrcene
US9364509B2 (en) 2009-03-04 2016-06-14 Regenera Pharma Ltd. Therapeutic uses of mastic gum fractions
US10806763B2 (en) 2009-03-04 2020-10-20 Regenera Pharma Ltd. Compositions of polymeric myrcene
WO2010100650A2 (en) 2009-03-04 2010-09-10 Regenera Pharma Ltd. Therapeutic uses of mastic gum fractions
US10307449B2 (en) 2009-03-04 2019-06-04 Regenera Pharma Ltd. Compositions of polymeric myrcene
US10251923B2 (en) 2009-03-04 2019-04-09 Regenera Pharma Ltd. Therapeutic uses of mastic gum fractions
US10159680B2 (en) 2010-09-07 2018-12-25 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
WO2012032523A2 (en) 2010-09-07 2012-03-15 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
US10561670B2 (en) 2010-09-07 2020-02-18 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
US9271949B2 (en) 2010-09-07 2016-03-01 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
EP3581177A2 (en) 2010-09-07 2019-12-18 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
EP3363448A1 (en) 2017-02-15 2018-08-22 Phytoitalia SRL Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them
WO2019170239A1 (en) 2018-03-08 2019-09-12 Phytoitalia Srl Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them

Similar Documents

Publication Publication Date Title
IL154888A (en) Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis
HUP0302131A2 (en) Pharmaceutical tramadol salts, pharmaceutical compositions containing them
AU2002235930A1 (en) A process for the manufacture of a herbal composition comprising a matrine
RS77904A (en) Oral administration form for difficulty soluble basic active ingredients which are applied orally
ES2187300A1 (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
HUP0402142A2 (en) Composition of estrogen/gestagen combination, preparation and application thereof
GR1003868B (en) Evaluation of the wound healing, antioxidant and cytostatic properties of mastic and its element and relative applications
WO2005076761A3 (en) Composition for preenting a cold
WO2005065639A3 (en) Novel pharmaceutical compositions
MXPA06000332A (en) Novel solid pharmaceutical composition comprising amisulpride.
MXPA05008843A (en) Therapeutic system comprising amoxicillin and clavulanic acid.
TNSN06072A1 (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
WO2006103119A3 (en) Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
WO2020190900A8 (en) Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof
WO2012010938A3 (en) Pharmaceutical composition of cefditoren pivoxil
WO2021054535A3 (en) Stabilized efinaconazole-containing pharmaceutical composition comprising combination of chelating agent, antioxidant, and acid
EP1232748A4 (en) Substituted nitrobenzene derivatives as medicines and other useful uses thereof
GR1004402B (en) Evaluation of the antioxidant and cytoprotective ability of 5-(ethylidene-2oxo-tetrahydro-pyranyl-4) acetic acid and extracts from olives. olive oil, oil mill effluents and olive tree leaves and applications thereof
HU0200980D0 (en)
GB0128071D0 (en) Medicament
MX2021014830A (en) CONJUGATES OF <i>π</i>-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS.
NO20005341D0 (en) Treatment of depression and pharmaceutical compositions for this
WO2003103567A3 (en) Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors
WO2003006668A3 (en) Haptoglobin Derived Antioxidants
WO2011028416A3 (en) Oral medication for the treatment of hemorrhoids and method of use